The estimated Net Worth of Lou Basenese is at least $104 Thousand dollars as of 25 August 2021. Mr. Basenese owns over 50,000 units of ENDRA Life Sciences Inc stock worth over $12,267 and over the last 5 years he sold NDRA stock worth over $91,500. In addition, he makes $0 as Independent Director at ENDRA Life Sciences Inc.
Louis has made over 6 trades of the ENDRA Life Sciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 50,000 units of NDRA stock worth $91,500 on 25 August 2021.
The largest trade he's ever made was selling 50,000 units of ENDRA Life Sciences Inc stock on 25 August 2021 worth over $91,500. On average, Louis trades about 7,143 units every 33 days since 2020. As of 25 August 2021 he still owns at least 49,068 units of ENDRA Life Sciences Inc stock.
You can see the complete history of Mr. Basenese stock trades at the bottom of the page.
Louis J. Basenese serves as Independent Director of the Company. Mr. Basenese is the Founder and Chief Analyst of Disruptive Tech Research, LLC, an independent equity research and advisory firm focused exclusively on disruptive technology companies that has served the investment management community since June 2014. Since 2005, Mr. Basenese has also managed The Basenese Group, LLC, a consulting business focused on communications and business development for private and public small and microcap businesses. Mr. Basenese holds an M.B.A. in Finance from the Crummer Graduate School of Business at Rollins College and a Bachelor of Arts from the University of Florida. He is also a former Series 7 and Series 66 license holder. Mr. Basenese’s experience with investor relations and business development of technology-focused companies, as well as financing and strategic planning, provides him with the qualifications and skills necessary to serve as a member of our Board of Directors.
Louis Basenese is 42, he's been the Independent Director of ENDRA Life Sciences Inc since 2020. There are 10 older and no younger executives at ENDRA Life Sciences Inc. The oldest executive at ENDRA Life Sciences Inc is Michael Harsh, 65, who is the Independent Director.
Lou's mailing address filed with the SEC is 3600 GREEN COURT, SUITE 350, , ANN ARBOR, MI, 48105.
Over the last 8 years, insiders at ENDRA Life Sciences Inc have traded over $893,199 worth of ENDRA Life Sciences Inc stock and bought 413,648 units worth $301,877 . The most active insiders traders include Group Ag Ubs, Capital Advisors, Llc Conra..., and Alexander Y Tokman. On average, ENDRA Life Sciences Inc executives and independent directors trade stock every 61 days with the average trade being worth of $5,922. The most recent stock trade was executed by Group Ag Ubs on 27 August 2024, trading 3,715 units of NDRA stock currently worth $2,043.
endra life sciences is bringing new capabilities to ultrasound. our photo-acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. we’re proud to have a global installed base of leading institutions using our nexus-128 system, the only 3d imaging solution for imaging anatomy, physiology and labeled molecular targets. the nexus 128 is a preclinical photoacoustic computed tomography (ct) scanner for small animal imaging. the system is used for simple, fast, non-invasive quantification of physiological parameters such as tumor vasculature without ionizing radiation. the fully-3d imaging technology used by the nexus 128 provides increased sensitivity compared to slice-based scanners, and dynamic (4-d) photoacoustic ct scans allow for applications such as quantification of probe uptake. the nexus 128 is currently being used by top imaging laboratories around the globe.
ENDRA Life Sciences Inc executives and other stock owners filed with the SEC include: